Related Experiment Videos
Increased production of malondialdehyde in patients with HIV infection
A Sönnerborg1, G Carlin, B Akerlund
1Department of Infectious Diseases, Roslagstull Hospital, Stockholm, Sweden.
Abstract:
The mean plasma content of malondialdehyde (MDA) in 30 patients in different stages of HIV infection was found to be about 30% higher than that in controls. The phenomenon was not correlated to the degree of immunodeficiency and was noted early in the course of the disease. This indicates a higher degree of basal lipid peroxidation, which might contribute to the tissue damage seen in these patients. A new reverse phase liquid chromatography method was used for quantitative measurements of MDA in plasma after reaction of this compound with thiobarbituric acid.
Insights
HIV patients show elevated malondialdehyde (MDA) levels, indicating increased lipid peroxidation early in the disease. This heightened oxidative stress may contribute to tissue damage in individuals with HIV infection.
Area of Science:
- Biochemistry
- Immunology
- Clinical Medicine
Background:
- Human Immunodeficiency Virus (HIV) infection is associated with increased oxidative stress.
- Lipid peroxidation is a key indicator of oxidative damage.
- Understanding oxidative stress markers in HIV is crucial for managing disease progression and complications.
Purpose of the Study:
- To quantify plasma malondialdehyde (MDA) levels in patients with varying stages of HIV infection.
- To investigate the relationship between MDA levels and the degree of immunodeficiency in HIV patients.
- To explore the potential role of lipid peroxidation in HIV-associated tissue damage.
Main Methods:
- Quantitative measurement of plasma malondialdehyde (MDA) using a novel reverse-phase liquid chromatography method.
- MDA was quantified after reaction with thiobarbituric acid.
- Comparison of MDA levels between 30 HIV patients and a control group.
Main Results:
- Mean plasma MDA levels were approximately 30% higher in HIV patients compared to controls.
- Elevated MDA levels were observed early in the course of HIV infection.
- No significant correlation was found between MDA levels and the degree of immunodeficiency.
Conclusions:
- Patients with HIV infection exhibit increased basal lipid peroxidation, as evidenced by elevated plasma MDA.
- This heightened lipid peroxidation occurs early in HIV disease and is independent of immunodeficiency severity.
- Increased lipid peroxidation may be a contributing factor to the observed tissue damage in HIV infection.